glp 1 thyroid cancer Glucagon-like peptide receptor agonist use and risk of cancer: Scandinavian cohort study GLP-1 Medications and Thyroid Cancer
Description
and J.T
The tennis star tried workouts, high-step routines, and experimented with multiple diets like vegan, vegetarian, and even high-protein plans
Lancet 406 , 14841496 (2025)
Quick Eligibility Check: Do I Qualify
Efficacy, safety, and mechanistic insights of cotadutide, a dual receptor glucagon-like peptide-1 and glucagon agonist
Participants received lifestyle counseling with recommendations for a hypocaloric diet (500 kcal/day deficit) and increased physical activity, alongside trial medication
